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Abstract
Cognitive decline is one of the many characteristics of aging.
Reduced long-term potentiation (LTP) and long-term depression
(LTD) are thought to be responsible for this decline, although the
precise mechanisms underlying LTP and LTD dampening in the old
remain unclear. We previously showed that aging is accompanied
by the loss of cholesterol from the hippocampus, which leads to
PI3K/Akt phosphorylation. Given that Akt de-phosphorylation is
required for glutamate receptor internalization and LTD, we
hypothesized that the decrease in cholesterol in neuronal
membranes may contribute to the deficits in LTD typical of aging.
Here, we show that cholesterol loss triggers p-Akt accumulation,
which in turn perturbs the normal cellular and molecular
responses induced by LTD, such as impaired AMPA receptor inter-
nalization and its reduced lateral diffusion. Electrophysiology
recordings in brain slices of old mice and in anesthetized elderly
rats demonstrate that the reduced hippocampal LTD associated
with age can be rescued by cholesterol perfusion. Accordingly,
cholesterol replenishment in aging animals improves hippocampal-
dependent learning and memory in the water maze test.
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Introduction
Aging is associated with cognitive decline, such that individuals
older than 65 develop cognitive deficits or age-associated memory
impairments. The hippocampus, a brain structure that is central to
the formation of declarative and other types of memory, is particu-
larly sensitive to aging. However, these impairments are not
paralleled by an increase in neuronal death (Burke & Barnes, 2006),
indicative that more subtle mechanisms must be affected by aging
to produce memory decline.
We previously showed that the phosphorylated form of the
serine–threonine kinase Akt (p-Akt) accumulates in old hippo-
campal neurons, both in vivo and in vitro (Martin et al, 2008,
2011; Trovo` et al, 2013), which probably reflects the strong need
for survival signaling. Nevertheless, the counter effect of robust
survival might be reduced performance. In fact, p-Akt phosphor-
ylation negatively regulates long-term depression (LTD), a key
process in learning and memory (see below and Peineau et al,
2007).
The accumulation of p-Akt with age may be the result of different
processes. We previously observed that the increase with age of the
cholesterol hydroxylating enzyme cholesterol 24-hydroxylase
(CYP46A1), the major catabolic enzyme of cholesterol in the brain
(Lund et al, 2003), triggers cholesterol loss-dependent, ligand-
independent, activation of the TrkB receptor and, consequently, Akt
phosphorylation (Martin et al, 2008, 2011; Sodero et al, 2011a,b). A
second mechanism driving the increase in p-Akt with age is also
linked to cholesterol loss, and it involves the increase in plasma
membrane sphingomyelin, similarly contributing to ligand-independent
TrkB phosphorylation and PI3K/Akt activation (Trovo` et al, 2011).
Increased PI3K/Akt activity in old neurons also seems to arise from
the constitutive increase with age of interleukin 1B (IL-1B) activity
and from the age-associated detachment from the plasma membrane
of the PIP2 binding protein, myristoylated alanine-rich C kinase
substrate (MARCKS: Trovo` et al, 2013). Altered binding of MARCKS
to the membrane favors the accumulation of PIP3 in the synaptic
fraction of old mice, with the subsequent increase in Akt phosphory-
lation (Trovo` et al, 2013).
Activity-dependent changes in synaptic strength, such as long-
term potentiation (LTP) and long-term depression (LTD) of synaptic
transmission, are considered to be the cellular substrates of learning
and memory (Neves et al, 2008; Collingridge et al, 2010). Competi-
tive interactions between these forms of synaptic plasticity have
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been proposed to participate in memory storage (Diamond et al,
2005; Nicholls et al, 2008; Ge et al, 2010). Indeed, glycogen
synthase kinase 3 beta (GSK3b) determines whether NMDA receptor
activation induces or inhibits LTD (Peineau et al, 2007). Moreover,
the activation of protein phosphatase 1 (PP1) during LTD dephosph-
orylates GSK3b at Ser9, resulting in its activation and receptor inter-
nalization. Since p-Akt is a GSK3b inhibitor, PP1-mediated Akt
dephosphorylation further contributes to the enhancement of GSK3b
activity. Significantly, GSK3b and Akt dephosphorylation are
impaired by okadaic acid, a compound that also blocks LTD by
inhibiting PP1 (Peineau et al, 2007). Conversely, activation of
NMDA receptors leads to the stimulation of PI3K/Akt pathway
during LTP, provoking the phosphorylation of GSK3b at Ser9 to
prevent LTD. Thus, it appears reasonable to assume that the loss of
cholesterol and the consequent enhancement of PI3K/Akt activity
that occurs in the hippocampus during aging will have a detrimental
effect on LTD and, consequently, on cognition. Since most studies
coincide that aging is accompanied by a decreased propensity to
develop LTD (Lee et al, 2005; Billard & Rouaud, 2007; Ahmed et al,
2011), we investigated here whether and how this is related to age-
associated constitutive cholesterol loss.
Results
Impaired LTD-induced Akt dephosphorylation in the
aged hippocampus
The magnitude of the LTD response seems to depend on the efficacy
of AMPAR internalization, which is in turn dependent on Akt
dephosphorylation, GSK3b activation, and receptor endocytosis.
Accordingly, in an aged hippocampus in which the equilibrium is
displaced toward pAkt (see Introduction), incomplete pAkt dephos-
phorylation would result in a poor LTD response. To test this predic-
tion, p-Akt levels were measured in hippocampal slices of young (4
month old; 4M) and old (20 month old; 20M) mice, in unstimulated
control conditions, and after pharmacological induction of LTD. In
control conditions, there was 1.89  0.298 fold more p-Akt in old
than in young mice (P = 0.041, Fig 1A), and moreover, NMDA trig-
gered a significant dephosphorylation of p-Akt in hippocampal slices
from young but not old mice (Fig 1A). In control experiments, the
normalization of Akt to b-actin showed that there was no change in
total Akt following stimulation and that the amount of p-Akt/b-actin
only decreased in young mice after NMDA stimulation (Fig 1A).
To test the possibility that the reduced capacity to dephosphory-
late Akt upon stimulation of the aged hippocampus is related to the
loss of cholesterol in the synaptic fraction (Martin et al, 2008;
Sodero et al, 2011a,b), we replenished cholesterol in the
membranes of hippocampal slices from 20M mice. Exposing slices
to 30 lM cholesterol-methyl-b-cyclodextrin (cholesterol-MbCD) and
5 lM cholesterol for 60 min reduced the levels of p-Akt to
47%  10.3 of the 20M controls, levels similar to those found in
slices from young mice (Fig 1B). To ascertain whether this replen-
ishment strategy did in fact restore cholesterol in the plasma
membrane, the levels of this sterol were measured in hippocampal
membrane fractions from young and old mice, before and after
exposure to the cholesterol-MbCD/cholesterol mix. The cholesterol:
total protein ratio was 0.420  0.053 in hippocampal membranes
from 4M mice and 0.326  0.044 in hippocampal membranes from
20M mice, confirming a loss of more than 20% of the cholesterol
with age (see Martin et al, 2008 and Sodero et al, 2011a,b). After
replenishment, the cholesterol levels in membranes from 20M mice
increased the cholesterol:protein ratio to 0.398 (0.070 lg), repre-
senting a recovery of 17.12% and a replenishment to 95% the levels
in hippocampal membranes from young mice.
In a control experiment, we tested the effect of adding cholesterol
to slices prepared from young mice, and in 4M acute hippocampal
slices, this did not alter the amount of p-Akt or Akt in basal condi-
tions (Fig 1C). Moreover, NMDA triggered p-Akt dephosphorylation
in both control and cholesterol-replenished slices, maintaining simi-
lar levels of p-Akt after stimulation in both cases (4M control +
NMDA: 75  8%; 4M cholesterol + NMDA: 81  5%; P = 0.694).
We recently demonstrated that in old mice, hippocampal
synapses contain less MARCKS in membranes, resulting in reduced
PI(4,5)P2 clustering and increased levels of PI(3,4,5)P3 and p-Akt
(Trovo` et al, 2013). To gain further insight into how cholesterol loss
during aging may increase pAkt, we investigated the relationship
between cholesterol loss and the association of MARCKS with the
plasma membrane. When hippocampal neurons were treated with a
low dose of the cholesterol-extracting drug MbCD, there was a
23.63  5.60% loss of cholesterol and a significant reduction in
membrane-bound MARCKS (Fig 1D). This reduction of MARCKS in
low-cholesterol membranes was not due to protein degradation, as
analyzing the membrane and supernatant fractions from control and
cholesterol-depleted neurons in Western blots demonstrated that
MbCD treatment provoked MARCKS detachment from the
membranes with its concomitant increase in the soluble fraction
(Fig 1D). Finally, we assessed whether the addition of cholesterol to
hippocampal slices prepared from young mice affected the distribu-
tion of MARCKS. Accordingly, we found that the addition of choles-
terol to acute hippocampal slices from 4M mice did not affect the
levels of MARCKS in the membrane fractions of those slices
(Fig 1E).
To demonstrate a functional connection between the reduction in
MARCKS at the membrane and Akt phosphorylation, the amount of
p-Akt was measured in 15 DIV neurons infected with lentiviral parti-
cles that express a shRNA designed to knockdown MARCKS expres-
sion (shMARCKS). MARCKS knockdown was associated with
increased p-Akt levels (Supplementary Fig S1), and the same effect
observed following the overexpression of a mutant form of MARCKS
that cannot bind PI(4,5)P2 (Trovo` et al, 2013). When cholesterol
was extracted from shMARCKS-treated neurons, a further increase
of Akt phosphorylation was observed, supporting our hypothesis
that cholesterol loss and membrane MARCKS detachment both
contribute to Akt phosphorylation (Supplementary Fig S1).
The phosphatase and tensin homolog deleted on chromosome
ten (PTEN) catalyzes the conversion of PI(3,4,5)P3 to PI(4,5)P2. It
was shown previously that during NMDA-induced LTD, PTEN is
recruited to the postsynaptic density (PSD) and that this is a strict
requirement for this type of LTD (Jurado et al, 2010). Hence, we
tested whether impaired p-Akt dephosphorylation after LTD in old
mice may be also due to deficits in PTEN activity. It might be
expected that deficient PI(3,4,5)P3 degradation by PTEN would lead
to the subsequent accumulation of PI(3,4,5)P3 and p-Akt hyperacti-
vation. Hence, PTEN levels were analyzed in the PSD fraction of
hippocampal slices from 4M and 20M mice, 30 min after NMDA-
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induced LTD. Recruitment of PTEN to the PSD fraction after NMDA-
LTD was similar in the membranes from young and old hippocam-
pal slices (Fig 2).
Together, these studies indicated that the loss of cholesterol in
the hippocampus of aged mice produces a strong increase in PI3K/
pAkt activity. Moreover, MARCKS detachment driven by cholesterol
loss, a protein previously shown to be associated with high pAkt
levels in the aged (Trovo` et al, 2013), seems also to be another
possible upstream determinant.
Cholesterol loss results in surface accumulation and impaired
endocytosis of AMPARs
To determine the extent to which the enhanced PI3K/pAkt driven
by cholesterol loss in the old affects the basic molecular machinery
of cognition, we analyzed AMPAR dynamics in hippocampal
neurons in vitro. In general, cells in vitro are particularly useful to
study and quantify receptor dynamics, and hippocampal neurons in
vitro are particularly suited as, like hippocampal cells in situ, they
also undergo a significant reduction in plasma membrane choles-
terol over time in vitro, which in turn is due to the increased expres-
sion of the enzyme CYP46A1 (Martin et al, 2008). Furthermore,
hippocampal neurons also experience a time-dependent increase in
p-Akt levels driven by cholesterol loss (Martin et al, 2011).
To study AMPAR dynamics, we measured the surface levels and
internalization rate of GluA2 containing receptors, since these are
the most abundant in the mature hippocampal neurons (Wenthold
et al, 1996; Malenka, 2003). Significantly more AMPARs were pres-
ent on the cell surface of 30 DIV neurons compared to 15 DIV
neurons (Fig 3A and B), and measurements of the area covered
indicated that GluA2-AMPARs were present in larger clusters on 30
DIV neurons (Fig 3C). By contrast, 15 and 30 DIV neurons
contained similar amounts of total GluA2 (Supplementary Fig S2A),
excluding any possibly differences in expression.
We analyzed the effect of neuronal stimulation on AMPAR endo-
cytosis in 15 and 30 DIV neurons. In the presence of 100 lM gluta-
mate, which induces AMPAR endocytosis in hippocampal cultures
through a mechanism also employed during LTD (Beattie et al,
2000; Man et al, 2000), weaker surface GluA2 staining was evident
in 15 DIV neurons. By contrast, there was no such effect on the
number of surface AMPARs in 30 DIV neurons (Fig 3A and B),
suggesting that internalization is impaired in the older neurons.
Indeed, when the levels of internalized GluA2-AMPARs were
measured using an antibody-feeding strategy followed by acid wash
(see Materials and Methods), receptor internalization in 15 DIV
neurons increased by 33% in the presence of 100 lM but not in 30
DIV neurons (Fig 3D–G). To test whether the reduction in the levels
of cholesterol in these older cells might be responsible for the
weaker receptor internalization of 30 DIV neurons, these cells were
incubated with the cholesterol-MbCD (30 lM) and cholesterol
(5 lM) replenishment mix. Under these conditions, there was a
significant loss of surface AMPARs on 30 DIV neurons stimulated
with glutamate (Fig 4A and B). Indeed, the levels of cholesterol in
the neuronal membranes were measured after replenishment, and
in 30 DIV hippocampal neurons, the cholesterol-MbCD/cholesterol
mix produced a 19% increase in membrane cholesterol: the choles-
terol levels in membrane preparations rose from 0.144  0.002 to
0.171  0.011 lg cholesterol/lg of protein. By contrast, the total
levels of GluA2 were not affected by cholesterol replenishment
in vitro or in vivo (Supplementary Figs S2A and S3).
This second series of experiments indicates that the loss of
cholesterol with aging may perturb certain aspects of cognition by
virtue of defective AMPAR internalization, justifying the reduced
LTD typical at this stage of life.
Cholesterol loss affects the lateral mobility of AMPA receptors
In order to study how changes in cholesterol levels may affect
AMPAR behavior in more detail, we next measured AMPAR lateral
diffusion. LTD requires the rapid redistribution of receptors away
from the synapse by lateral diffusion (Tardin et al, 2003), and the
subsequent internalization of the displaced receptors by endocytosis
is essential to sustain LTD (Carroll et al, 1999; Beattie et al, 2000).
Mechanistically, it has been proposed that the mobility of synaptic
Figure 1. p-AKT dephosphorylation after LTD is impaired in old mice.
A p-Akt levels in acute hippocampal slices prepared from young (4M) and old (20M) mice in control conditions or 1 h after NMDA-LTD induction were assessed in
Western blots. The quantification shows that in control conditions, the levels of p-Akt are 50% higher in 20M than in 4M mice. Stimulation with 20 lM NMDA
induced p-Akt dephosphorylation in 4M but not in 20M mice. The bar plots show the levels of p-Akt in young and old mice, corrected for total Akt and for b-actin, in
controls and after stimulation. The quantification of total Akt/b-actin shows that the total Akt levels do not change after stimulation. The levels of p-Akt/Akt after
stimulation were: 4M = 0.75  0.081 (n = 5 animals, P = 0.014), and 20M = 1.01  0.047, (n = 5 animals, P = 0.767). The levels of p-Akt/b-actin after stimulation
were: 4M = 0.76  0.065, (n = 5 animals, P = 0.004), and 20M = 1.05  0.15, (n = 8 animals, P = 0.726). The levels of total Akt/b-actin after stimulation were:
4M = 1.10  0.101 (n = 5 animals, P = 0.340) and 20M = 1.08  0.170, (n = 8 animals, P = 0.664).
B Western blot and quantification showing that addition of cholesterol to acute slices from 20M mice restores the basal levels of p-Akt observed in young mice [20M +
chol = 0.47  10.3 (n = 5 animals, P = 0.0008)].
C Control experiments show that the addition of cholesterol to acute hippocampal slices from 4M mice does not effect on the levels of p-Akt and total Akt, or on p-Akt
dephosphorylation after 20 lM NMDA stimulation. p-Akt/b-actin: 4M + chol = 0.96  0.139 (n = 5 animals, P = 0.805); Akt/b-actin: 4M + chol = 1.16  0.138 (n = 5
animals, P = 0.311). The levels of p-Akt/Akt after stimulation were: 4M + chol = 0.81  0.051 (n = 5 animals, P = 0.0143).
D Lower levels of the PIP2-binding protein MARCKS were found in membrane preparations from 15 DIV cholesterol-depleted neurons compared to controls. The plot
shows the amount of MARCKS attached to the membrane relative to controls: control neurons = 1.00; MbCD-treated neurons = 0.688  0.11 (P = 0.045, n = 5
different cultures). The Western blots below show the membrane-supernatant distribution of MARCKS in control neurons or after cholesterol depletion by MbCD. As
can be seen in the blots, MbCD provokes a reduction in the MARCKS present in the membrane fraction (M) with a concomitant 26.33  6.4% increase in the
supernatant (SN, P = 0.02, n = 3 different cultures).
E The Western blot corresponds to control experiments showing that the addition of cholesterol to hippocampal slices from 4M mice does not affect the amount of
MARCKS found in membrane fractions: 4M + chol = 0.80  0.124 (P = 0.187, n = 3 animals).
Data information: In (A-E), the presented values are relative to controls, considered as 1. The P-values correspond to 2-sided t-test.
Source data are available for this figure.
◀
ª 2014 The Authors EMBO Molecular Medicine Vol 6 | No 7 | 2014
Mauricio G Martin et al Cholesterol loss drives poor LTD in old rodents EMBO Molecular Medicine
905
but not extra-synaptic receptors during LTD requires PI(3,4,5)P3
depletion (Arendt et al, 2010). Hence, the loss of cholesterol in the
older cells would probably affect AMPAR displacement by lateral
diffusion, similar to, and possibly as a consequence of reduced
internalization (see Figs 3 and 4). To test this prediction, we used
quantum-dot-based single molecule tracking (Fig 5 and Supplemen-
tary Methods).
The instantaneous diffusion coefficients (D) for confined (within
synapses, Din) and non-confined (beyond synapses, Dout) AMPARs
were 0.023  0.0028 lm2/s and 0.0613  0.0099 lm2/s, respec-
tively, in 15 DIV neurons (Fig 5D), similar to those in neurons
cultured for 30 DIV: Din = 0.0269  0.0085 lm2/s and
Dout = 0.086  0.0213 lm2/s (Fig 5E). Control experiments where
synapses were stained using the synaptic marker mitotracker (Groc
et al, 2004) showed that the Din obtained for sites of confinement
corresponded to Din particles within synapses (Supporting Informa-
tion). As opposed to the basal levels, in the presence of 100 lM
glutamate, there was an increase of the mean Din and Dout in 15 DIV
neurons (Fig 5D), while glutamate was unable to induce any change
in AMPAR mobility in 30 DIV neurons, neither within nor beyond
synapses (Fig 5E). To determine whether this reduced mobility in
30 DIV neurons was the consequence of these cells’ lower choles-
terol content, we repeated these measurements in the presence of
the cholesterol-replenishing solution (see above). Cholesterol
replenishment did not affect AMPAR diffusion in control conditions,
although glutamate stimulation increased the mobility of synaptic
AMPARs, increasing the Din value in the cholesterol reinforced
cells from 0.0250  0.0035 lm2/s to 0.0337  0.0047 lm2/s
(P = 0.0254, Fig 5F).
Since glutamate was used instead of NMDA to stimulate hippo-
campal neurons in culture, control experiments were performed to
compare the effect of NMDA and glutamate on AMPAR lateral
diffusion. We observed that the addition of 20 lM NMDA to 15 DIV
neurons also increased the values of Din and Dout, and no
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Figure 3. Surface GluA2-AMPARs accumulate in low-cholesterol hippocampal neurons.
A, B The surface staining of GluA2-containing AMPARs (A) is significantly higher in 30 DIV than in 15 DIV neurons (15 DIV = 1.00  0.28; 30 DIV = 2.73  0.27;
P < 0.0001, n = 3). Stimulation with glutamate (100 lM) resulted in decreased GluA2 staining of 15 DIV (15 DIV glut = 0.62  0.095; Pcontrol, glut = 0.0310; n = 3)
but not 30 DIV neurons (30 DIV glut = 2.86  0.219; Pcontrol, glut = 0.053; n = 3), indicating that low-cholesterol neurons have a reduced capability to endocytose
AMPARs in response to ligand. Fluorescence intensity (FI/area) quantified in the processes of neurons is shown in (B).
C Quantification of the area of GluA2-AMPARs clusters in 15 and 30 DIV neurons indicates that larger receptor clusters form in low-cholesterol neurons (average area
15DIV: 0.055  0.0042 lm2, 30 DIV: 0.086  0.0053 lm2, P = 0.0009, n = 3 different cultures).
D, E Fluorescence images show the internalized AMPARs in 15DIV and 30DIV neurons, before and after glutamate stimulation. The fluorescence images correspond to
higher magnifications of the regions indicated in the insets. Glutamate exposure resulted in increased AMPAR internalization in 15 DIV neurons (D) and 5 min after
glutamate addition the fluorescence intensity (FI)/area measured in the processes increased from 1  0.06 to 1.33  0.12 (t-test, P = 0.0082, n = 4). Glutamate
addition did not increase AMPAR internalization in 30 DIV neurons (E). The values of FI/area in the processes were 1  0.082 and 0.88  0.048 (t-test, P = 0.252,
n = 3).
Data information: The values represent the mean  s.e.m. relative to controls. n: number of different experiments. The data were compared using Mann-Whitney non-
parametric t-test.
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differences were observed with respect to the D values obtained by
glutamate stimulation (Supplementary S4A and B). However,
NMDA stimulation of cholesterol-replenished 15 DIV neurons did
not produce any differences compared to controls (Supplementary
Fig S4B).
NMDA-LTD is impaired in aged animals in a manner dependent
on cholesterol loss
In light of the fact that the loss of membrane cholesterol in old
neurons perturbs AMPAR membrane internalization and lateral
diffusion, two key events needed for LTD, this event was further
studied by electrophysiology. Application of NMDA (30 lM) for
4 min induced strong depression in hippocampal slices obtained
from 2-month-old (2M) mice, whereas no LTD was observed in
slices from 20M mice (Fig 6A). Furthermore, LTD was efficiently
induced in slices from middle-aged, 10-month-old (10M) mice,
confirming that reduced LTD in the 20M mice is part of the aging
phenotype and manifested in early adulthood (Fig 6B).
To determine whether the impaired LTD in the old was due to
the loss of cholesterol that occurs naturally in the hippocampus in
later life (see Introduction), hippocampal slices from old mice were
incubated with the cholesterol replenishment mix (see above) and
cholesterol replenishment was seen to rescue NMDA-induced LTD
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Figure 4. Glutamate addition decreases the level of surface AMPARs in cholesterol-replenished 30 DIV neurons.
A The surface AMPAR staining decreased in cholesterol-replenished 30 DIV neurons after a 10-min incubation with glutamate. The boxes on the right correspond to
high-magnification images of the regions indicated in the insets.
B The bar plot shows the quantification of the fluorescence intensity (FI)/area (mean  s.e.m., relative to the cholesterol + glutamate condition) in the processes of
control and cholesterol-replenished neurons. No differences in the FI/area values were found in control, glutamate-stimulated (control = 1.67  0.12,
glutamate = 1.35  0.07; P = 0.053; n = 3) or cholesterol-replenished unstimulated neurons (control = 1.67  0.12; cholesterol = 1.63  0.19; P = 0.87; n = 3).
Stimulation of cholesterol-replenished neurons (chol + glut) provoked a significant decrease in the surface GluA2 staining (control = 1.67  0.12; cholesterol +
glutamate = 1.00  0.12; P = 0.0018; n = 3). The data were compared using Mann-Whitney non-parametric t-test.
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Figure 5. Lateral diffusion of GluA2-AMPARs is altered in low-cholesterol hippocampal neurons after LTD induction.
A Phase contrast and fluorescence images showing the processes of hippocampal neurons where GluA2 subunits were labeled with quantum dots.
B GluA2-AMPARs were labeled using an anti GluA2 antibody and a biotinylated anti-mouse Fab fragment conjugated to streptavidin-coated quantum dots.
C Image showing the reconstructed trajectories of individual GluA2-AMPARs.
D, E Glutamate stimulation increases the diffusion of synaptic and extra-synaptic AMPARs in 15 DIV but not 30 DIV neurons. 15DIV: Di control = 0.023  0.0028 lm2/s,
Di glut = 0.0298  0.0045 lm2/s (P = 0.0201), Dout control = 0.0613  0.0099 lm2/s, Dout glut = 0.0917  0.0149 lm2/s (P = 0.0054). 30 DIV: Din
control = 0.0269  0.0085 lm2/s, Din glut = 0.0231  0.0044 lm2/s (P = 0.4048) and Dout control = 0.086  0.0213 lm2/s, Dout glut = 0.0771  0.0207 lm2/s
(P = 0.5228).
F The addition of cholesterol to 30 DIV neurons restores the response of synaptic AMPARs to glutamate. Din chol = 0.0250  0.0035 lm2/s, Din chol +
glut = 0.0337  0.0047 lm2/s (P = 0.0254).
Data information: In individual AMPAR tracking experiments the diffusion coefficients calculated from all the trajectories analyzed (ranging from 250 to 500 obtained
from at least five different cultures) have a one-tail distribution. The effect of glutamate in single experiments has been studied using non-parametric Mann-Whitney
tests. The mean values of the medians follow a normal distribution and thus groups of experiments were compared using unpaired t-test.
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in old hippocampal slices (Fig 6A). Strikingly, the LTD in slices
from old animals treated with the cholesterol was very similar to
that in untreated slices from young mice. To rule-out any unspecific
effects, slices from young mice (i.e., with normal cholesterol levels)
were exposed to the cholesterol replenishment mix and their electro-
physiological response was indistinguishable from that of the
controls (Fig 6A). To determine whether cholesterol loss is suffi-
cient to impair LTD, cholesterol was removed from hippocampal
slices obtained from 10M mice with the drug MbCD, resulting in a
net loss of 28.65  16.77% cholesterol and a marked reduction in
LTD (Fig 6B).
Next, we infused cholesterol for 14 days into the lateral ventricle
of 20M mice, after which the animals were sacrificed and hippocam-
pal slices were prepared for electrophysiological recordings. While
NMDA induced a brief and transient LTD in the vehicle-treated
group, a significant and long-lasting depression was registered in
slices from cholesterol-infused aged mice (Fig 6C). No significant
differences in the input-output curves were observed in the condi-
tions tested, indicating that basal synaptic transmission is not
affected by changes in cholesterol (Supplementary Fig S5).
Constitutive cholesterol loss impairs LTD in the aged:
in vivo studies
To demonstrate the relevance of the age-associated cholesterol loss
in vivo, we measured LTD in the hippocampus of anesthetized 2M
and 20M Wistar rats. This animal model was used as old rats are
more resistant than mice to the anesthetic and recording procedures,
and as rat aging is also accompanied by a loss of cholesterol in the
hippocampus (Martin et al, 2008).
To induce hippocampal LTD in rats, concentric bipolar stimulat-
ing electrodes were placed in the ipsilateral CA3 field for ortho-
dromic activation of the CA1 field, where evoked potentials were
recorded (Fig 7A). In this way, it could be seen that the LTD
induced by local application of NMDA was robust in young adult
rats and impaired in old animals (Fig 7B).
We tested whether the impaired LTD in old rats could be rescued
by enhancing the availability of cholesterol, as observed in mouse
hippocampal slices (Fig 6). Before proceeding with the study, we
established optimal conditions to guarantee that cholesterol injected
into the hippocampus would be able to infuse into a wide enough
region to include the area recorded by the electrode. Thus, two injec-
tions of a cholesterol solution containing the fluorescent cholesterol
derivative Bodipy-cholesterol (3.5 lM) were applied to the apical
dendritic layer of the CA1 region of an adult rat, 1 mm apart
(Fig 7A). To verify adequate diffusion of Bodipy-cholesterol to the
recording site, hippocampal sections were examined by fluorescence
microscopy 60 min later, when the injected Bodipy-cholesterol could
be seen to have infused into all the tissue located between the injec-
tion sites (Fig 7A). In addition, to avoid tissue damage in the record-
ing zone, the evoked potentials were recorded from an intermediate
location between the injection sites (Fig 7A). Having established
these parameters, when we examined the electrophysiological
recordings, a very strong LTD was evident in old animals that
received a hippocampal injection of cholesterol 60 min before LTD
induction (Fig 7B). As a control, young rats were also injected with
cholesterol 60 min before the LTD induction, although no differ-
ences were observed between the treated and untreated animals
(Fig 7B). To rule-out variability between animals, the same rat was
used as both the experimental and control case, that is, the choles-
terol solution was injected into the hippocampus of one hemisphere
and control solution into the contralateral hippocampus. The sterol
specificity was tested by measuring LTD in aged rats injected in the
hippocampus with oleic acid-MbCD or with stigmasterol-MbCD,
neither of which restored LTD (Supplementary Fig S6), thereby
confirming the specificity of cholesterol in the phenotype observed.
Chronic central cholesterol treatment enhances spatial learning
and memory
The clear effect of cholesterol replenishment in rescuing impaired
LTD in old animals prompted us to test whether the infusion of
cholesterol into the brain of old rats would improve some of the
cognitive deficits typical of this stage of life. Therefore, 19-month-
old rats were perfused in the lateral ventricle for 1 month with
a cholesterol replenishment solution (containing the 300 lM
cholesterol-MbCD complex + 5 lM free cholesterol dissolved in arti-
ficial cerebrospinal fluid – aCSF). Subsequently, the spatial learning
ability of the animals was evaluated in the reference version of the
Morris water maze, an established hippocampal-dependent task
(see Materials and Methods) where aged animals typically exhibit
impaired learning of the location of the hidden escape platform
(Gallagher et al, 1993).
Post hoc statistical comparison of the learning curves demon-
strated significant differences for the two groups of rats (repeated-
measure ANOVA, F1,11 = 5.848, P = 0.016: Fig 8A). A more detailed
Figure 6. NMDA-LTD is lost with age and restored by cholesterol replenishment.
A NMDA-LTD was observed in slices of 2-month-old mice (2M, ○), but it was absent in 20-month-old mice (20M, ♦), yet cholesterol replenishment restored LTD in old
slices (20M + chol, M gray filled). Cholesterol perfusion did not have any effect on 2M slices (2M + chol, □ gray filled). Empty boxes indicate the period of cholesterol
perfusion. Gray squares represent the time of NMDA application. The plot shows the average  s.e.m. of the responses collected from the last 20 min of the
recordings. Values, 2M: 49.05  2.94%; 2M + chol: 30.82  7.68% (P2M, 2M+chol = 0.137); 20M: 82.69  8.02%; 20M + chol: 48.61  5.50% (P2M, 20M = 0.014; P20M,
20M+chol = 0.0093).
B Cholesterol depletion impaired NMDA-LTD in middle-aged hippocampal slices. Treatment with MbCD 2 h prior to NMDA addition abolished NMDA-LTD in 10-month-
old mice. Control (○), cholesterol depleted (■). The average  s.e.m. of the responses collected from the last 20 min of the recordings for the control (38.43  3.68%)
and MbCD-treated groups (90.82  8.45%; P = 0.0003) are plotted on the right.
C Intraventricular infusion of cholesterol in old mice restored NMDA-LTD. Field excitatory postsynaptic potentials (fEPSPs) were recorded from hippocampal slices of 24-
month-old mice infused with cholesterol (♢) or vehicle (♦) in the lateral ventricle for 14 days. A significant NMDA-LTD was obtained in slices prepared from
cholesterol-infused mice, but no LTD was observed in the vehicle-treated group. The plot shows the average  s.e.m. of the responses collected from the last 20 min
of the recordings for control (IV vehicle: 104.02  3.64%) and cholesterol-treated group (IV chol: 68.05  17.34%; P = 0.0286).
Data information: The sample traces recorded at the times indicated as 1, 2, and 3 for each condition are shown in (A), (B), and (C). In all the cases, the data were
compared using Mann-Whitney non-parametric t-tests and the number of animals (n) is shown in the figure.
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analysis of each training day indicated that cholesterol-treated
rats outperformed their controls in the water maze on day 4
(F1,2 = 7,707; P = 0.008). The Bonferroni post hoc test indicated
significant differences to find the hidden platform between
cholesterol-treated rats and controls in trial 11 (P = 0.019). One day
after the acquisition of spatial learning, the strength of long-term
spatial memory was evaluated in a probe trial (i.e., free swimming
without platform). During the probe trial, rats that received choles-
terol spent more time swimming in the quadrant of the pool that
contained the platform during training (target quadrant) than those
that did not (t18 = 2.659, P = 0.016: Fig 8B and C). No differences in
swim speed or thigmotactic behavior were found during spatial
training or in the probe trial. These results show that cholesterol
perfusion can rescue learning and memory in old rats.
Discussion
Hippocampal cholesterol loss during aging occurs in rodents and
humans (reviewed in Ledesma et al, 2012), and the data presented
here suggest that this loss contributes to cognitive decay in the aged.
This conclusion is supported by the rescue of the poor LTD in the
aged following the addition of cholesterol to hippocampal slices,
either in aCSF and directly into the hippocampus. Similarly, intra-
ventricular addition of cholesterol also rescues the reduced learning
and memory abilities of old rats.
In addition to the effect of the loss of cholesterol in relation to
LTD and cognitive abilities, the data presented here, together with
data from previous work, provide evidence for the molecular mech-
anism underlying this age-dependent impairment of LTD. Indeed,
previous studies have shown that the loss of cholesterol in the
hippocampus of aged animals drives an increase in TrkB/PI3K activ-
ity and p-AKT accumulation (Martin et al, 2008, 2011; Trovo` et al,
2011, 2013). These data are reinforced here by the demonstration
that hippocampal extracts from old animals have high levels of
active p-Akt. While part of the increased p-Akt activity can be
explained by the activity of the TrkB/PI3K pathway (Martin et al,
2008), the data presented here indicate that MARCKS detachment
may also contribute to the effects of cholesterol loss. In fact, we
recently described that MARCKS detachment from hippocampal
synapses of old mice is responsible for the decreased PI(4,5)P2
levels and high p-Akt activity (Trovo` et al, 2013). Thus, in mecha-
nistic terms, the increase in PI3K activity is a major biochemical
change determined by the age-associated loss of cholesterol that,
together with membrane MARCKS detachment, results in PI(3,4,5)
P3 and p-Akt accumulation.
Considering the robust anti-apoptotic role of activated Akt
(Airaksinen & Saarma, 2002; Huang & Reichardt, 2003; Zheng &
Quirion, 2004), an obvious conclusion from our findings is that the
loss of cholesterol with aging plays an important role in the survival
of aging neurons. Conversely, the age-associated loss of cholesterol
appears to be detrimental for certain functions, and LTD requires
NMDA-dependent p-Akt dephosphorylation in order to activate the
GSK3b, which in turn regulates AMPAR internalization (Peineau
et al, 2007). This mechanism does not appear to be operative in old
neurons, again most likely due to natural cholesterol loss. Indeed,
the levels of p-Akt in response to NMDA are higher in hippocampal
extracts from old mice than young mice, and when cholesterol
levels are restored, p-Akt levels diminish significantly to those found
in younger animals. Although we cannot rule that the high levels of
p-Akt in the aged tissue are the consequence of reduced Akt dephos-
phorylation by PP1, we have sufficient evidence that part of the
problem is the increase in PI3K activity (see Trovo` et al, 2013; and
data herein). Moreover, we show here that AMPARs accumulate at
the surface of 30 DIV neurons and that they undergo a very low rate
of internalization upon stimulation, both processes that are depen-
dent on membrane cholesterol levels. In fact, PI3K activation has
been reported to increase cell surface expression of AMPARs by
facilitating receptor insertion (Man et al, 2003).
From our data, we infer that AMPAR accumulation at the cell
surface is not simply due to changes in membrane composition as a
result of cholesterol loss but rather that these receptors are blocked
by their interaction with other adaptor molecules. Indeed, single
molecule tracking experiments demonstrated that the simple addi-
tion of cholesterol at 30 DIV does not augment the Din values in
unstimulated conditions. In fact, increases in Din are only observed
in cholesterol-treated neurons after glutamate stimulation. This
observation concurs with the reduction in surface GluA2-AMPARs
only occurring after stimulation in cholesterol-replenished cells. The
efficient internalization of AMPARs is essential for LTD, and it
requires a decrease in PI(3,4,5)P3 to favor synaptic actin depolymer-
ization, PSD95 degradation, and reduced surface AMPAR expression
(Horne & Dell’Acqua, 2007). Accordingly, PSD95 degradation after
NMDA stimulation does not occurring in synaptic fractions prepared
from old animals or in cholesterol-depleted neurons in vitro. Thus,
the reduced lateral mobility of synaptic AMPARs after stimulating
neurotransmitter can be seen as the consequence of surface accu-
mulation due to defective internalization.
Since MARCKS is required for PIP2 clustering and PLCc activity
(Trovo` et al, 2013), and therefore for actin depolymerization and
receptor internalization, the poor association of MARCKS to the
plasma membrane in low-cholesterol membranes can also contrib-
ute to the impairment of LTD. The reason for MARCKS detaching
from membranes after cholesterol removal remains unclear. One
possibility could be that the myristoyl moiety of this protein inter-
acts more weakly with cholesterol-depleted membranes. Further-
more, since high intracellular calcium leads to MARCKS membrane
detachment and high calcium is typically a feature of old cells
(Arbuzova et al, 1998; Trovo` et al, 2013), the cholesterol loss-
dependent detachment of MARCKS could also be driven through an
increase in calcium permeability provoked by cholesterol loss.
For practical reasons, our study focused on the consequences
and underlying mechanisms of one lipidic change occurring during
aging: hippocampal cholesterol reduction. However, it must be born
in mind that other lipid alterations also occur at this stage of life,
such as the increase in sphingomyelin and ceramide, and the
decrease of poly-unsaturated fatty acids (reviewed in Ledesma et al,
2012). These changes could also contribute to the cognitive and
motor deficits typical at this stage of life, and as a matter of fact, we
showed that the SM/cholesterol ratio increases during aging, leading
to changes in receptor endocytosis (Trovo` et al, 2011). Thus, future
studies will be needed to determine how other changes in
membrane lipid composition during aging participate in the cogni-
tive deficits of the old.
Finally, it is important to note that blood cholesterol does not
cross the blood brain barrier, making any beneficial effect of
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increased cholesterol in the diet unlikely and strongly unrecom-
mended. In fact, the increase in circulatory cholesterol will have a
number of deleterious consequences due to the effect in the vascula-
ture (atherosclerosis), consequently affecting the function of all
organs. Hence, in theory, strategies to inhibit brain cholesterol loss
could improve the cognitive deficits associated with aging.
Materials and Methods
Cell cultures and reagents
Hippocampal neurons from 18-day-old rat embryos were cultured
for 15 or 30 DIV. Glutamate was added at final concentrations of
100 lM during 15 min, while NMDA was added at 30 lM for
5 min, and the cells were washed and kept in fresh N2 medium for
15 min prior to their analysis. Cholesterol was replenished during
30 min at 37°C using cholesterol-MbCD complex (30 lM, Sigma)
supplemented with cholesterol (5 lM) in N2 medium. Cholesterol
was depleted by treating 15 DIV hippocampal neurons with MbCD
(0.5 mM) for 2 h. Finally, the cholesterol levels obtained after treat-
ments were measured in membrane pellets prepared from hippo-
campal neurons in culture or from hippocampal slices using the
Amplex Red Cholesterol Assay kit (Invitrogen).
Hippocampal slice recordings
The hippocampus of mice was dissected into ice-cold ACSF that
was oxygen-saturated with carbogen (95% O2/5% CO2). Field
excitatory postsynaptic potentials (fEPSPs) were recorded using a
glass electrode (filled with ACSF, 3–7 MO) inserted into the apical
dendritic layer of the CA1 area. LTD was induced by applying
NMDA (30 lM) dissolved in ACSF for 4 min (Li et al, 2004). The
cholesterol was added for 60 min as cholesterol-MbCD and 5 lM
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Figure 7. Cholesterol rescues LTD and cognition in old rats.
A Sagittal section of the hippocampus of anesthetized rats injected with
fluorescent Bodipy-cholesterol. The upper panel shows the merged phase
contrast and fluorescence images. The sites where Bodipy-cholesterol was
injected (1), the Schaffer stimulation site (2), and the recording site (3) are
indicated. Lower panel: magnification of the fluorescence image showing
that Bodipy-cholesterol diffuses from the injection sites (1) to the recording
zone (2). The image corresponds to the magnification of one section of
hippocampus, 60 min after cholesterol injection into the st. radiatum (40×
1.25 IMM OIL Leica laser-scanning confocal microscopy).
B LTD was registered in 2-month-old anesthetized animals (2M, ○), but it was
impaired in 20-month-old animals (20M, ♦). Cholesterol injection into the
stratum radiatum of the old animals rescued LTD (20M + cholesterol, M
gray filled), but it had no effect in young animals (2M + chol, ☐ gray filled).
The plot shows the evolution of the fEPSPs following the NMDA-inducing
LTD protocol (n = 5). Average fEPSPs were built over 10-min periods (1 trial
per min), and the same individuals were employed for control and
cholesterol treatment using the left or right hippocampus. Representative
traces are shown of fEPSPs recorded in the stratum radiatum in vivo before
(solid traces) and 40 min after NMDA-LTD (dotted traces) in 2M, 20M, and
20M rats injected with cholesterol (20M + cholesterol). The plot shows the
average  s.e.m. values of the responses collected from the last 40 min of
the recordings from 2M (51.11  4.73), 2M + cholesterol (2M + cholesterol:
40.83  3.74; P2M, 2M + chol = 0.151), 20M (107.03  2.78; P2M,
20M = 0.007), and 20M rats injected with cholesterol (20M + chol:
64.12  6.30; P20M, 20M + chol = 0.008). The data were compared using
Mann-Whitney non-parametric t-tests.
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cholesterol in aCSF solution. LTD was induced after 30 min in the
presence of cholesterol by adding NMDA to the cholesterol solu-
tion for 4 min. For cholesterol depletion, hippocampal slices were
incubated for 2 h with 0.5 mg/ml MbCD prior to inducing LTD.
The drug and control studies were interleaved for both age groups,
and the input-output curves were recorded without the addition of
picrotoxin.
Osmotic pump implantation in mice and in vivo
cholesterol administration
ALZET osmotic mini-pumps (model 2004; ALZET) were filled with
either cholesterol solution [300 lM cholesterol-MbCD (Sigma)
supplemented with 5 lM cholesterol in aCSF] or the vehicle alone
(aCSF), secured by the flow moderator, connected to the brain
cannula (Alzet Brain Infusion Kit 3) by flexible tubing, and primed
with 0.9% saline for 24 h at 37°C. For implantation, mice were
sedated (chloralhydrate 30 mg/ml by intraperitoneal injection) and
locally anaesthetized (xylocaine 1% wt/vol, subcutaneous). Subse-
quently, the cannula was stereotaxically placed into the left lateral
ventricle and glued into the skull, while the pump was inserted
subcutaneously on the back.
Animals received a continuous infusion of cholesterol or vehicle
for 14 days, after which they were sacrificed, their brains removed,
and hippocampal slices were prepared for electrophysiological
recordings as indicated.
In vivo electrophysiology
Male Wistar rats (2 or 20 months old) were anesthetized with
urethane (1.2 g/kg, i.p.) and fastened to a stereotaxic device, main-
taining their body temperature at 37°C with a heated blanket.
Concentric bipolar stimulating electrodes were placed in the ipsilat-
eral CA3 field (mm from bregma, AP: 1.2; L: 2.6; V: 3.5) for ortho-
dromic activation of the CA1 field. The stimulus intensity was set to
produce a CA1 population spike of ~40% of the maximum ampli-
tude. Recording and drug injections were achieved through glass
micropipettes (1–4 MO) connected to a high-impedance headstage.
The signals were amplified and acquired (10 kHz sampling rate)
using low noise multi-channel system recording hardware and soft-
ware (Reutlingen, Germany).
Cholesterol was pressure-ejected into the apical dendritic layer of
CA1 through a recording pipette filled with cholesterol-MbCD
complex (300 lM) plus cholesterol (5 lM, Sigma-Aldrich). Two injec-
tions delivered 1 mm apart were applied 60 min before LTD was
induced, while subsequent evoked potentials were recorded from an
intermediate location. Averaged evoked fEPSPs were collected each
minute before (30 min) and for up to 90 min after LTD induction.
LTD was induced in st. radiatum of CA1 region by local application
of NMDA (NMDA 500 lM plus NaCl 1 M). The volume was adjusted
to avoid noticeable effects on evoked potentials in control experi-
ments when only solvent was injected (NaCl 1 M). The fEPSP was
measured as the maximum slope of the initial negative phase.
Bodipy-cholesterol injection and histology
Fluorescent Bodipy-cholesterol (5 mM stock in DMSO, Invitrogen)
was dissolved in saline solution (at 3.5 lM, maximum solubility)
and injected into the st. radiatum of the CA1 area (apical dendritic
layer). Two glass pipettes were placed 500 lm anteroposterior to
the recording pipette, and the microdrops (two drops on both sides,
1 mm apart) were adjusted (~200 nl) to limit the volume of the
bathed tissue. The LTD protocol commenced 60 min later. Finally,
the brains were removed and 100 lm sagittal cryostat sections were
rapidly obtained. Slices were examined by fluorescence microscopy
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Figure 8. Cholesterol improves learning and memory in old rats.
A The spatial abilities of 20M rats subjected to intra-ventricular infusion of
control or cholesterol solution were evaluated in the Morris water maze.
The animals were trained three times each day over 4 days, and the
learning curves were plotted for the two groups. Average group distance
(cm) to find the hidden platform across trials is shown, whereby
cholesterol-treated rats (n = 9) outperformed their controls (n = 11) in
the water maze on day 4 (repeated-measure ANOVA, F1,2 = 7,707;
P = 0.008), and significant differences were found in trial 11 (Bonferroni
post hoc test, P = 0.019).
B, C One day after acquisition of spatial learning, the strength of long-term
spatial memory was evaluated in a probe trial without the platform. The
percentage time spent in the quadrant of the pool that previously
contained the platform (Q1) was significantly higher for cholesterol-
treated animals compared to the rats that received the vehicle alone
(two-sided t-test, P = 0.016), as shown in (B). Time spent in the target
quadrant over the total time spent in the target and the opposite
quadrant: Q1/(Q1 + Q3) is shown in (C). While vehicle-treated rats
performed at chance level (0.5 represented by a dashed line), cholesterol-
treated rats had a good spatial memory index (two-sided t-test
P = 0.012). The results clearly show that cholesterol treatment improved
spatial memory in old rats.
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(560–610 nm) to determine the extension of the tissue infused with
cholesterol.
Immunocytochemistry
To identify surface AMPARs, unpermeabilized control or treated
neurons were fixed and stained with an antibody recognizing an
extracellular epitope of the rat GluA2 subunit (BD pharmingen). To
measure the ratio of surface/total AMPARs, antibody-feeding experi-
ments were performed. Briefly, live cells were incubated with the
same anti GluA2 antibody (5 lg/ml) for 10 min at 20°C in condi-
tioned cell medium to minimize endocytosis. The cells were then
washed briefly and returned to the medium at 37°C for agonist treat-
ment and staining, as indicated elsewhere (Carroll et al, 1999).
Surface and internalized AMPARs were labeled with fluorescent
secondary antibodies (Invitrogen) before and after permeabilization
respectively. The fluorescence intensity corresponding to the surface
and internalized GluA2 was measured in a defined area, and the
ratio of the internalized GluA2 was calculated as internalized
GluA2/(internalized + surface GluA2). The values were corrected
for the control (unstimulated) conditions, considered as 100%. For
each experiment, the same parameters were used to acquire the
images in all the conditions.
Internalized GluA2-AMPARs were measured using the same anti-
body-feeding protocol followed by acid stripping. In these experi-
ments, the antibodies bound to receptors on the cell surface after
agonist treatment was removed. The cells were chilled in ice-cold
TBS and washed with 0.5 M NaCl/0.2 M acetic acid for 4 min
(Carroll et al, 1999). The intracellular AMPARs were identified by
immunofluorescence following cell permeabilization.
GluA2 live cell staining and single-particle tracking
GluA2-containing AMPARs were labeled with quantum dot nano-
particles (Invitrogen), and single-particle tracking and their trajec-
tory were analyzed as described in detail in the Supporting
Information.
Rat surgery and osmotic pump implantation
A chronic brain infusion cannula (Alzet brain infusion kit 2-Alzet
Corporation, Palo Alto, CA, USA) was implanted into the right
lateral ventricle of the brain by stereotaxis at the following coordi-
nates relative to bregma: 0.85 mm posterior, + 1.1 mm lateral,
and 4.0 mm deep according to the atlas of Paxinos and Watson
(Paxinos et al, 1985). The infusion cannula was attached through
catheter tubing to an Alzet miniosmotic pump (model 2006; flow
rate: 0.15 ll/h). Approximately 36 h prior to subcutaneous implan-
tation of the osmotic minipump into the rat0s midscapular region,
the osmotic minipump was primed by immersion in sterile 0.9%
saline at 37°C.
To determine whether the beneficial effects observed at the elec-
trophysiological level have a cognitive counterpart, 19-month-old
rats were intraventricularly perfused for 4 weeks with a solution of
cholesterol-MbCD (300 lM) + cholesterol (5 lM) dissolved in aCSF.
Subsequently, the spatial ability of the animals was evaluated in the
reference version of the Morris water maze.
Water maze learning – Spatial training
The water maze (Morris, 1984) was a black circular pool (2 m diam-
eter, 45 cm high) filled with water (30 cm deep) at 24  1°C. An
invisible escape platform (11 cm diameter) was placed at a fixed
location equidistant from the sidewall and middle of the pool and
submerged 1.5 cm below the surface of the water. The behavior of
the animal (latency, distance, swim speed, and navigation path)
was monitored using a video camera mounted on the ceiling above
the center of the pool and a computerized tracking system (Ethovi-
sion 1.90, Noldus IT, the Netherlands). Rats completed three trials
per day over four consecutive days using a 60 s intertrial interval
and a 90 s cut-off to locate the platform in a trial. If the animal failed
to escape within 90 s, it was guided to the platform by the experi-
menter and it was allowed to stay there for 30 s. During the training
procedure, the location of the platform remained constant in one
virtual quadrant of the maze, while the starting position for each
trial varied among the four equally spaced positions around the
perimeter of the maze. On day 5, we conducted a probe trial in
which the escape platform was removed from the pool and the rat
was allowed to swim for 60 s. The trial began with the rat in the
quadrant opposite to that which previously housed the training plat-
form and the time spent in each quadrant was recorded. In order to
discriminate against the level of chance, a ratio was defined as the
percent time spent in the target quadrant over the total time spent in
the target and the opposite quadrant (chance level at 50%). In addi-
tion, the time the animal needed to cross the exact point of the loca-
tion of the platform for the first time during the probe trial was used
as an indicator of spatial memory. Cognitive evaluation of the
spatial abilities of the rats was performed by a trained experimenter
blind to the animals’ treatment.
Statistical analysis
Groups of data with a normal distribution and equal variances were
compared using the unpaired parametric t-test, while data with
different variances were compared using the unpaired t-test with
Welch’s correction. Groups of data where a Gaussian distribution
could not be assumed were compared with non-parametric Mann-
Whitney test.
Animal handling
All the experiments were performed in accordance with European
Union guidelines (2010/63/UE) regarding the use of laboratory
animals. Thirteen aged (20–24 months) and five young adult
(2 months) Male Wistar rats were used for in vivo LTD, and 24
old male Wistar rats were used for the water maze experiments.
Seventeen old (20 months) and 17 adult (4 and 10 months) male
C57BL6 mice were used for LTD measurements, and approxi-
mately 30 animals of each age were used for biochemical experi-
ments performed in acute hippocampal slices. Embryos from
pregnant E18 Wistar rats were used to prepare hippocampal
primary cultures.
Supplementary information for this article is available online:
http://embomolmed.embopress.org
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